The Sleep After Breast Cancer (ABC) Study - Examining Sleep Changes and Biomarkers Among Breast Cancer Patients
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT07341503
- Status
- Recruiting
Conditions
- Anatomic Stage I Breast Cancer AJCC v8
- Anatomic Stage II Breast Cancer AJCC v8
- Anatomic Stage III Breast Cancer AJCC v8
- Breast Carcinoma
- Hormone Receptor-Positive Breast Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Non-Interventional Study — OTHERNon-interventional study
Study Details
This study is being done to learn more about breast cancer patients' experiences with sleep changes during cancer treatment, identify possible reasons for poor sleep quality, and to find out how stress, social support, and living environment affect sleep.
Key Dates
- Start date
- Aug 18, 2025
- Status verified
- Sep 2025
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 100 participants (estimated)
Arms
- Arm: ObservationalPatients undergo collection of cheek swab, saliva, and hair samples, wear a wrist sleep tracking device, and complete surveys throughout the study. Additionally, patients have their medical records reviewed on study.
Primary Outcome Measure
Total sleep duration [ Time Frame: Through study completion, an average of 9 months ]
Central Contacts
- The Ohio State University Comprehensive Cancer Center800-293-5066
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | Electra D. Paskett, MSPH, PhD, FAACR (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
By condition
By specialty
By research site
Related Studies
- Impact of Dietary Inflammatory Potential on Breast Cancer RiskRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize TrialPHASE3 · Recruiting · Alliance for Clinical Trials in Oncology · Ann Arbor, Michigan
- Topical or Oral Minoxidil for the Treatment of Endocrine Therapy-Induced Alopecia in Patients With Stage I-IV Breast CancerEARLY_PHASE1 · Recruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Testing the Addition of Anti-Cancer Drug, ZEN003694 (ZEN-3694) and PD-1 Inhibitor (Pembrolizumab), to Standard Chemotherapy (Nab-Paclitaxel) Treatment in Patients With Advanced Triple-Negative Breast CancerPHASE1 · Recruiting · National Cancer Institute (NCI) · Boston, Massachusetts